These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8623161)

  • 1. The effect of oral immunization on corneal allograft survival.
    He YG; Mellon J; Niederkorn JY
    Transplantation; 1996 Mar; 61(6):920-6. PubMed ID: 8623161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditions affecting enhanced corneal allograft survival by oral immunization.
    Ma D; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1835-46. PubMed ID: 9727406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunisation as a strategy for enhancing corneal allograft survival.
    Ma D; Mellon J; Niederkorn JY
    Br J Ophthalmol; 1997 Sep; 81(9):778-84. PubMed ID: 9422933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic phenotype of hosts orally immunized with corneal alloantigens.
    Ma D; Li XY; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):744-53. PubMed ID: 9538881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of tissue culture on corneal immunogenicity.
    Gabric N; Dekaris I; Suman L; Karaman Z; Mravicic I
    Exp Eye Res; 1999 Mar; 68(3):277-82. PubMed ID: 10079135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of lymph nodes in corneal alloimmunization and graft rejection.
    Yamagami S; Dana MR
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1293-8. PubMed ID: 11328742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants.
    Zhu SN; Yamada J; Streilein JW; Dana MR
    Transplantation; 2000 Mar; 69(5):1008-13. PubMed ID: 10755569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL; Mayhew E; Hegde S; Niederkorn J
    Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway".
    Sano Y; Streilein JW; Ksander BR
    Transplantation; 1999 Oct; 68(7):963-70. PubMed ID: 10532535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of MHC-matched corneal allografts in Th1-deficient hosts.
    Hargrave SL; Hay C; Mellon J; Mayhew E; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1188-93. PubMed ID: 15037587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts.
    Dekaris IJ; Yamada JJ; Streilein WJ; Dana RM
    Curr Eye Res; 1999 Nov; 19(5):456-9. PubMed ID: 10520223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.